[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341810-105":59,"doc-detail-341810-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","hyena-detects-oncogenes-activated-by-distal-enhancers-in-cancer","HYENA detects oncogenes activated by distal enhancers in cancer","","Somatic structural variations (SVs) in cancer reshuffle genome DNA, reposition regulatory elements, and change 3D genome organization. Enhancer hijacking can move distal enhancers to activate proto-oncogenes, yet most studies focus on protein-coding targets. HYENA is a computational method using tumor whole-genome and transcriptome data, applying rank-based regression to link elevated gene expression with SVs, identifying 108 candidate oncogenes across 1146 adult tumors, including non-coding genes. TOB1-AS1 is activated in 10% of pancreatic cancers and promotes invasion and metastasis.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hyena-detects-oncogenes-activated-by-distal-enhancers-in-cancer/341810/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hyena-detects-oncogenes-activated-by-distal-enhancers-in-cancer/341810.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is enhancer hijacking in cancer, and why does it matter?","Question",{"text":113,"@type":114},"Enhancer hijacking occurs when somatic structural variations relocate distal enhancers, causing proto-oncogenes to become activated. It contributes to tumorigenesis by altering gene regulation through genome architecture.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does HYENA identify oncogenes activated by distal enhancers?",{"text":118,"@type":114},"HYENA analyzes tumor whole-genome and transcriptome sequencing data using a rank-based regression model to detect genes whose elevated expression is associated with somatic SVs.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the study find about non-coding genes and TOB1-AS1?",{"text":122,"@type":114},"HYENA identified 108 candidate oncogenes, including many non-coding genes. TOB1-AS1, a long non-coding RNA, is activated by various SV types in about 10% of pancreatic cancers and high expression promotes cell invasion and metastasis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341810,1790112094,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","HYENA detects oncogenes activated by distal enhancers in cancer  \nAnqi Yu 1 ,†, Ali E. Yesilkanal 1 ,†, Ashish Thakur2 , Fan Wang1 , Yang Yang1 , William Phillips 1 , Xiaoyang Wu1 ,3 , Alexander Muir 1 ,3 , Xin He2 , Francois Spitz2 and Lixing Yang 1 ,2 ,3 , *  \n1 Ben May Department for Cancer Research, University of Chicago, Chicago, IL, USA  \n2 Department of Human Genetics, University of Chicago, Chicago, IL, USA  \n3 University of Chicago Comprehensive Cancer Center, Chicago, IL, USA  \n* To whom correspondence should be addressed. Tel: +1 773 834 2948; Email: [lixingyang@uchicago.edu](lixingyang@uchicago.edu)[ ](lixingyang@uchicago.edu)†The first two authors should be regarded as Joint First Authors.  \nAbstract  \nSomatic structural variations (SVs) in cancer can shuffle DNA content in the genome, relocate regulatory elements, and alter genome organization. Enhancer hijacking occurs when SVs relocate distal enhancers to activate proto-oncogenes. However, most enhancer hijacking studies have only focused on protein-coding genes. Here, we develop a computational algorithm ‘HYENA’ to identify candidate oncogenes (both protein-coding and non-coding) activated by enhancer hijacking based on tumor whole-genome and transcriptome sequencing data. HYENA detects genes whose elevated expression is associated with somatic SVs by using a rank-based regression model. We systematically analyze 1146 tumors across 25 types of adult tumors and identify a total of 108 candidate oncogenes including many non-coding genes. A long non-coding RNA TOB1-AS1 is activated by various types of SVs in 10% of pancreatic cancers through altered 3-dimensional genome structure. We find that high expression of TOB1-AS1 can promote cell invasion and metastasis. Our study highlights the contribution of genetic alterations in non-coding regions to tumorigenesis and tumor progression.  \nGraphical abstract  \nIntroduction  \nAt the mega-base-pair scale, linear DNA is organized into topologically associating domains (TADs) (1), and gene expression is regulated by DNA and protein interactions governed by 3D genome organization. Enhancer–promoter interactions are mostly confined within TADs (2–4) . Noncoding somatic single nucleotide variants (SNVs) in promoters and enhancers have been linked to transcriptional changes in nearby genes and tumorigenesis (5) . Structural  \nvariations (SVs), including deletions, duplications, inversions, and translocations, can dramatically change TAD organization and gene regulation (6) and subsequently contribute to tumorigenesis. Previously, we discovered that TERT is frequently activated in chromophobe renal cell carcinoma by relocation of distal enhancers (7), a mechanism referred to as enhancer hijacking (Figure 1A). In fact, many oncogenes, such as BCL2 (8), MYC (9), TAL1 (10), MECOM/EVI1 (11), GFI1 (12), IGF2 (13), PRDM6 (14) and CHD4 (15), can be acti-  \nReceived: April 4, 2024. Revised: June 7, 2024. Editorial Decision: July 1, 2024. Accepted: July 11, 2024 © The Author(s) 2024. Published by Oxford University Press on behalf of Nucleic Acids Research.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution License ([https:](https://creativecommons.org/licenses/by/4.0/)[//](https://creativecommons.org/licenses/by/4.0/)[creativecommons.org](https://creativecommons.org/licenses/by/4.0/)[/](https://creativecommons.org/licenses/by/4.0/)[licenses](https://creativecommons.org/licenses/by/4.0/)[/](https://creativecommons.org/licenses/by/4.0/)[by](https://creativecommons.org/licenses/by/4.0/)[/](https://creativecommons.org/licenses/by/4.0/)[4.0](https://creativecommons.org/licenses/by/4.0/)[/](https://creativecommons.org/licenses/by/4.0/)), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.  \nPAGE 2 OF 15 Nucleic Acids Research, 2024, Vol. 52, No. 16, e77  \nFigure 1. Outline of enhancer hijacking and HYENA algorithm. (A) Mech","cbCaihVJsrb7dWzn","https://ap.wps.com/l/cbCaihVJsrb7dWzn","pdf",2634874,15,"English","# Abstract\n# Introduction\n## Enhancer hijacking and 3D genome organization\n## Algorithms and limitations\n# Results\n## Candidate oncogenes across tumor types\n## TOB1-AS1 activation and functional impact\n# Discussion","[{\"question\":\"What is enhancer hijacking in cancer, and why does it matter?\",\"answer\":\"Enhancer hijacking occurs when somatic structural variations relocate distal enhancers, causing proto-oncogenes to become activated. It contributes to tumorigenesis by altering gene regulation through genome architecture.\"},{\"question\":\"How does HYENA identify oncogenes activated by distal enhancers?\",\"answer\":\"HYENA analyzes tumor whole-genome and transcriptome sequencing data using a rank-based regression model to detect genes whose elevated expression is associated with somatic SVs.\"},{\"question\":\"What did the study find about non-coding genes and TOB1-AS1?\",\"answer\":\"HYENA identified 108 candidate oncogenes, including many non-coding genes. TOB1-AS1, a long non-coding RNA, is activated by various SV types in about 10% of pancreatic cancers and high expression promotes cell invasion and metastasis.\"}]","HYENA detects oncogenes activated by distal enhancers in cancer | PDF",1790043922,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d302398ba94ea1d2f6de253425b2d1b9.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c6423947b7689fa58a446aac2c7e69f.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/54fedee808938bbe3ff8ef9a8157690b.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/451790ca0170b7802d4979f1625e1c6d.webp",980,1268]